-
Recently, two domestically produced new drugs have been certified as orphan drugs overseas
Time of Update: 2021-12-01
On November 22, Yasheng Pharmaceutical issued an announcement that the European Commission (EC) recently granted its Class 1 new drug oribatinib (HQP1351) orphan drug qualification for treatment Chronic Myeloid Leukemia (CML) .
-
Health Commission: Newly diagnosed 32 local cases on the 14th
Time of Update: 2021-12-01
As of 24:00 on November 14, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1347 confirmed cases (including 17 severe cases), a total of 92,332 cured and discharged cases, and a total of 4,636 deaths.
-
up to date!
Time of Update: 2021-12-01
The Xie Xiaoliang team of Peking University's Biomedical Frontier Center has made important progress in the research of neutralizing antibodies by using single-cell sequencing technology, and the drugs developed have been used in clinical treatment .
-
The Drug Evaluation Center of the State Food and Drug Administration released the "Annual Report on the Current Status of Clinical Trials for New Drug Registration in China (2020)"
Time of Update: 2021-12-01
The follow-up drug review center will report on new drug registration clinical trials on an annual basis, relying on China's new drug registration clinical trial registration data, focus on regulatory innovation, improve regulatory effectiveness, strengthen communication with the industry in promoting the modernization of drug regulatory capabilities, and increase information transparency.
-
A variety of key drugs for new coronary pneumonia in my country enter clinical trials
Time of Update: 2021-12-01
A variety of key drugs for new coronary pneumonia in my country enter clinical trials A variety of key drugs for new coronary pneumonia in my country has entered clinical trials Beijing, November 17, reporter Yang Shu learned from the Ministry of Science and Technology recently that China has followed the three technical routes of inhibiting virus replication, blocking virus entry into cells, and regulating the human immune system.
-
Health Commission: 23 new cases were diagnosed on the 19th, including 3 cases in the local area
Time of Update: 2021-12-01
As of 24:00 on November 19, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1158 confirmed cases (including 12 severe cases), 92,656 cured and discharged cases, and 4,636 deaths.
-
The new version of the basic medicine adjustment starts the "double envelope" mode!
Time of Update: 2021-12-01
The spirit and opinion drafts of the relevant conferences that have flowed out before show that in addition to emergency medicines, exclusive varieties should be independently demonstrated, and classic prescriptions and consistency evaluations should be included first (may not be medical insurance drugs) .
-
A variety of new crown oral drugs have progressed to fight the epidemic and still need "combined punches"
Time of Update: 2021-12-01
Feature: A variety of new crown oral drugs have made progress Feature: A variety of new crown oral drugs have progressed and anti-epidemic still needs "combined boxing" Special pape
-
Live preview: Using auxiliary materials to help you complete the direct pressure process design
Time of Update: 2021-12-01
Speaker: Tobias Heß, Head of I&AD Pharma Translation: Bao Yang Budenheim China Sales Manager Tobias Hess has more than 11 years of experience in the field of pharmaceutical excipients and their development, production and application .
-
The pharmacy industry has set off a wave of listings, and corporate competition will intensify
Time of Update: 2021-12-01
In August, SpeciHealth, which mainly sells specialty drugs for oncology and other critical diseases, formally submitted a prospectus to the Hong Kong Stock Exchange and plans to list on the main board .
-
The Comprehensive Department of the State Food and Drug Administration publicly solicits opinions on the "Measures for the Supervision and Administration of Drug Operation and Use Quality (Draft for Solicitation of Comments)"
Time of Update: 2021-12-01
The "Measures for the Supervision and Administration of Drug Operation and Use Quality" have been revised and perfected and are now again open to the public for comments .
cn via e-mail before November 26, 2021, and the subject of the email should indicate "Feedback on Drug Operation and Use Measures" .
-
5 new cases in Japan on November 22: 4 in Liaoning and 1 in Yunnan
Time of Update: 2021-12-01
As of 24:00 on November 22, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1,006 confirmed cases (including 8 severe cases), a total of 92,882 cured and discharged cases, and a total of 4,636 deaths.
-
Japan's VHH antibody new crown treatment plan makes progress in animal experiments
Time of Update: 2021-12-01
Japan's VHH antibody new crown treatment program makes progress in animal experiments Japan's VHH antibody new crown treatment plan has made animal experiment progress Japan's VHH a
-
How to prevent about one million patients with sudden acute myocardial infarction every year in my country
Time of Update: 2021-12-01
Chest pain and sweating are the most typical symptoms of patients with acute myocardial infarction .
-
In November, many pharmaceutical companies achieved new breakthroughs in the field of antibiotics
Time of Update: 2021-12-01
According to the announcement, the daptomycin for injection developed by Sino-US East China was approved for listing in China in 2015 and is an important product in the company's anti-infective drug treatment field .
-
He used "a sugar pill" to keep Chinese children away from polio
Time of Update: 2021-12-01
He is the "Sugar Pill Grandpa", a pioneer in the development and production of polio vaccines in China, a pioneer in scientific and technological research, and the winner of the national honorary title of "People's Scientist"-Gu Fangzhou .
-
The National Pharmacopoeia Commission 2021 National Drug Standards to be Supplementary List Publicizes 9 types of excipients and 2 general technical methods for pharmaceutical packaging materials
Time of Update: 2021-12-01
Based on the deliberation of the preliminary application form, our committee has now determined the list of proposed supplementary topics for the improvement of national drug standards in 2021, which is now publicized, and the publicity period is 7 days .
-
Answers to common questions about the standards of pharmaceutical excipients in the 2020 edition of the Chinese Pharmacopoeia (1)
Time of Update: 2021-12-01
Please refer to https:// for the contact information of "Variety Guardian" in the "Chinese Pharmacopoeia" pharmaceutical excipient standard (third edition) .
-
Health Commission: Newly diagnosed 70 local cases on the 13th
Time of Update: 2021-12-01
As of 24:00 on November 13, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1,350 confirmed cases (including 19 severe cases), a total of 92,277 cured and discharged cases, and a total of 4,636 deaths.
-
Latest International Research: Fatty Acids in Palm Oil Promote Tumor Metastasis in Mice
Time of Update: 2021-12-01
The paper introduced that fatty acid intake and metabolic changes have always been thought to be related to cancer metastasis, which refers to the process by which cancer cells spread to other parts of the body .
